secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entrada Therapeutics, Inc. (TRDA)
CIK:        0001689375
Form:       8-K
Filed at:   2021-11-02T23:59:59+00:00
Accession:  0001104659-21-132980
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entrada Therapeutics files amended charter and bylaws in connection with IPO
----------------------------------------------------------------------------

- Authorizes 150M shares of common stock and 10M shares of undesignated preferred stock.
- Bylaws eliminate stockholder action by written consent, set procedures for proposals and nominations.
- Changes previously disclosed in S-1; effective upon IPO consummation on November 2, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689375/000110465921132980/0001104659-21-132980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689375/000110465921132980/tm2131671d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-132980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer